The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Ebert Charles D since year 2005.
The trader's CIK number is 1241752.
At the time of this reporting, Ebert Charles D is the Development of Actavis Plc .
(stock ticker symbol ACT).
See this page for all insider trading activities at Actavis Plc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2012-02-29||WPI||Watson Pharmaceuticals Inc||Sale||4,981||58.79||292,837|
|2012-02-29||WPI||Watson Pharmaceuticals Inc||Option Ex||1,000||25.64||25,640|
|2011-06-01||WPI||Watson Pharmaceuticals Inc||Sale||2,635||64.45||169,825|
|2011-03-03||WPI||Watson Pharmaceuticals Inc||Option Ex||7,500||48.85||366,375|
|2011-03-03||WPI||Watson Pharmaceuticals Inc||Sale||7,500||56.36||422,700|
|2010-12-06||WPI||Watson Pharmaceuticals Inc||Sale||3,639||51.00||185,589|
|2010-03-12||WPI||Watson Pharmaceuticals Inc||Option Ex||28,600||31.45||899,555|
|2010-03-12||WPI||Watson Pharmaceuticals Inc||Sale||28,600||40.87||1,168,796|
|2009-12-10||WPI||Watson Pharmaceuticals Inc||Sale||19,000||38.25||726,750|
|2009-12-10||WPI||Watson Pharmaceuticals Inc||Option Ex||19,000||27.14||515,660|
|2005-12-01||WPI||Watson Pharmaceuticals Inc||Sale||17,000||33.28||565,726|
|2005-11-22||WPI||Watson Pharmaceuticals Inc||Sale||12,400||33.18||411,369|
|2005-11-17||WPI||Watson Pharmaceuticals Inc||Sale||15,000||32.48||487,199|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ebert Charles D (Development of Actavis Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.